Free Trial

35,143 Shares in DuPont de Nemours, Inc. $DD Purchased by Mirae Asset Global Investments Co. Ltd.

DuPont de Nemours logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Mirae Asset Global Investments opened a new DuPont position, acquiring 35,143 shares worth approximately $4.6 million in the third quarter. Institutional investors and hedge funds own about 74% of the company’s stock.
  • DuPont reported quarterly EPS of $2.09 and revenue of $1.87 billion, beating analyst estimates of $1.87 and $1.84 billion, respectively. Analysts’ consensus rating is Moderate Buy, with a $165.88 average price target.
  • DuPont announced a quarterly dividend of $0.60 per share, equivalent to $2.40 annually and a 1.7% yield.
  • Interested in DuPont de Nemours? Here are five stocks we like better.

Mirae Asset Global Investments Co. Ltd. acquired a new position in DuPont de Nemours, Inc. (NYSE:DD - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 35,143 shares of the basic materials company's stock, valued at approximately $4,565,000.

Other hedge funds have also made changes to their positions in the company. Physician Wealth Advisors Inc. boosted its stake in DuPont de Nemours by 223.1% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company's stock valued at $27,000 after acquiring an additional 145 shares during the last quarter. Elevation Wealth Partners LLC boosted its stake in DuPont de Nemours by 168.5% in the second quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company's stock valued at $32,000 after acquiring an additional 150 shares during the period. DHJJ Financial Advisors Ltd. boosted its stake in DuPont de Nemours by 150.0% in the third quarter. DHJJ Financial Advisors Ltd. now owns 250 shares of the basic materials company's stock valued at $32,000 after acquiring an additional 150 shares during the period. Bangor Savings Bank bought a new position in shares of DuPont de Nemours during the third quarter valued at approximately $36,000. Finally, Compass Wealth Management LLC bought a new position in shares of DuPont de Nemours during the third quarter valued at approximately $39,000. Institutional investors and hedge funds own 73.96% of the company's stock.

Wall Street Analyst Weigh In

DD has been the topic of a number of analyst reports. Citigroup increased their price objective on shares of DuPont de Nemours from $162.00 to $176.00 and gave the stock a "buy" rating in a report on Wednesday. Zacks Research cut DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a report on Friday, July 17th. The Goldman Sachs Group reduced their price objective on shares of DuPont de Nemours from $159.00 to $153.00 and set a "neutral" rating for the company in a research note on Wednesday, September 30th. UBS Group increased their target price on DuPont de Nemours from $172.00 to $182.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Weiss Ratings reissued a "sell (d+)" rating on shares of DuPont de Nemours in a research report on Friday, October 30th. Twelve analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $165.88.

Read Our Latest Report on DD

DuPont de Nemours News Summary

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Several firms raised their price targets while maintaining bullish ratings: RBC lifted its target to $173 and kept an Outperform rating; Wells Fargo raised its target to $170 with an Overweight rating; UBS raised its target to $182 with a Buy rating; and Citi and Barclays each set targets of $176 with Buy or Overweight ratings. RBC price target article Wells Fargo price target article
  • Positive Sentiment: DuPont’s latest reported quarter beat earnings and revenue expectations, with EPS of $2.09 versus the $1.87 consensus and revenue of $1.87 billion versus $1.84 billion expected. A report also noted the shares gapped up following the results. Shares gap up following earnings article
  • Neutral Sentiment: A headline highlighted a new peptide-purification product, but the provided information does not detail its expected commercial impact. Peptide purification product article

DuPont de Nemours Price Performance

Shares of NYSE:DD opened at $144.77 on Friday. The business has a 50-day moving average of $133.07 and a two-hundred day moving average of $138.70. DuPont de Nemours, Inc. has a fifty-two week low of $111.15 and a fifty-two week high of $157.98. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.36 and a quick ratio of 1.82. The stock has a market capitalization of $19.55 billion, a P/E ratio of 64.92, a P/E/G ratio of 1.35 and a beta of 1.06.

DuPont de Nemours (NYSE:DD - Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 EPS for the quarter, beating the consensus estimate of $1.87 by $0.22. The company had revenue of $1.87 billion for the quarter, compared to the consensus estimate of $1.84 billion. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.09 earnings per share. On average, equities research analysts predict that DuPont de Nemours, Inc. will post 7.49 EPS for the current fiscal year.

DuPont de Nemours Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be paid a dividend of $0.60 per share. The ex-dividend date is Monday, November 30th. This represents a $2.40 annualized dividend and a yield of 1.7%. DuPont de Nemours's dividend payout ratio is presently 107.62%.

About DuPont de Nemours

(Free Report)

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company's product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

Featured Stories

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DuPont de Nemours Right Now?

Before you consider DuPont de Nemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.

While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines